MedPath

A study to determine a correction coefficient for the introduction of 55-gene classifier (55GC) into clinical practice, aimed at predicting the recurrence risk in Stage II/III colon cancer

Not Applicable
Recruiting
Conditions
Colon cancer
Registration Number
JPRN-UMIN000024159
Lead Sponsor
ational Defense Medical College and Kyushu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who had received preoperative therapy. (2) Patients with a previous malignancy, within 5 years of operation, except for tumors at the stage of carcinoma in situ.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath